Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose oliceridine pretreatment to reduce etomidate-induced myoclonus during anesthesia induction
ChiCTR2500108944Phase 4Not yet recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in myoclonus (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Myoclonus incidence and severity. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
myoclonus
Beyond the preview
Go deeper on ChiCTR2500108944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108944.